Steris (STE) Stock Price, Fundamentals & Analysis

What STE does

Steris (STE) is a stock in the Healthcare sector, within the Medical Devices industry, headquartered in Mentor, United States. The company provides infection prevention products and services across the United States, Ireland, and internationally. It operates through three segments — Healthcare, Applied Sterilization Technologies, and Life Sciences — offering cleaning chemistries, sterilizers, endoscope reprocessing systems, surgical tables, lights, and related maintenance and consulting services. With 17,937 employees, STE is part of the S&P 500.

Key numbers explained

• Price: 209.98 USD — the most recent trading price of one share.
• Trailing P/E ratio: 25.7 — the current share price divided by the last twelve months of earnings per share; a higher number can mean the market expects faster growth.
• Forward P/E ratio: 17.1 — the price relative to expected future earnings, which can look lower if earnings are forecast to grow.
• Dividend yield: 1.24% — the annual dividend as a percentage of the share price, showing the cash return to shareholders.
• Ex-dividend date: Sep 4, 2026 — the date after which a new buyer is no longer entitled to the next dividend payment.
• Share of earnings paid out as dividends: 31% — roughly one-third of earnings is returned to shareholders as dividends.
• Beta: 0.91 — a measure of volatility; below 1 means the stock has historically moved less than the overall market.
• 52-week range: 195.14 – 269.44 — the lowest and highest prices seen over the past year.

Recent news

Recent headlines include a piece on mid-cap stocks with open questions, a look at a Wall Street favorite with exciting potential alongside two stocks to brush off, and a question of whether STERIS stock is underperforming the Healthcare sector. Other articles note the stock is down since the last earnings report and examine whether it looks reasonable on earnings with cash flow slightly stretched, while one suggests STE could be below fair value as conference season returns.

What to watch

Investors typically watch how STE responds to changes in healthcare spending, regulatory decisions on sterilization and medical devices, and competition from peers such as Insulet Corporation (PODD), GE HealthCare (GEHC), Incyte (INCY), HCA Healthcare (HCA), Waters Corporation (WAT), Biogen (BIIB), and Cooper Companies (The) (COO). Broader factors include interest-rate moves, currency swings in international markets, and the company’s next earnings report on Nov 4, 2026.